reine Buchbestellungen ab 5 Euro senden wir Ihnen Portofrei zuDiesen Artikel senden wir Ihnen ohne weiteren Aufpreis als PAKET

Molecular Basis of Pulmonary Disease
(Englisch)
Insights from Rare Lung Disorders
McCormack, Francis X. & Panos, Ralph J. & Trapnell, Bruce C.

Print on Demand - Dieser Artikel wird für Sie gedruckt!

179,95 €

inkl. MwSt. · Portofrei
Dieses Produkt wird für Sie gedruckt, Lieferzeit ca. 14 Werktage
Menge:

Molecular Basis of Pulmonary Disease

Medium
Seiten
Erscheinungsdatum
Auflage
Erscheinungsjahr
Sprache
Hersteller
Vertrieb
Kategorie
Buchtyp
Warengruppenindex
Laenge
Breite
Hoehe
Gewicht
Relevanz
Referenznummer
Moluna-Artikelnummer

Produktbeschreibung

Comprehensive, state-of-the-art review of rare lung diseasesThoroughly sheds light on the molecular mechanisms that evoke the clinical presentation and engender treatment strategies for each rare lung diseaseCovers all aspects of such disorders as pulmonary alveolar proteinosis (PAP), pulmonary alveolar microlithiasis (PAM), inherited disorders of surfactant metabolism, and pulmonary arterial hypertension, to name just several
Chapter 1. A Clinical Approach to Rare Lung Diseases Ralph Panos, M.D.Chapter 2. Clinical Trials for Rare Lung DiseasesJeffrey Krischer, Ph.D.Chapter 3. Idiopathic and Familial Pulmonary Arterial HypertensionJean M. Elwing, M.D., Gail Deutsch, M.D., William C. Nichols, Ph.D., and Timothy LeCras, Ph.D., Chapter 4. LymphangioleiomyomatosisFrancis X. McCormack, M.D, and Elizabeth P. Henske, M.D., Ph.D.Chapter 5. Autoimmune Pulmonary Alveolar Proteinosis Bruce Trapnell, M.D., Koh Nakata, M.D., Ph.D., and Yoshikazu Inoue, M.D., Ph.D.Chapter 6. Mutations in Surfactant Protein C and Interstitial Lung DiseaseJames P. Bridges, Ph. D. and Ralph Panos, M.D.Chapter 7. Hereditary Hemorrhagic TelangiectasiaClaire Shovlin, M.D and S. Paul Oh, Ph.D. Chapter 8. Hermansky Pudlak SyndromeLisa Young, M.D. and Bill Gahl, M.D., Ph.D.Chapter 9. Alpha One Antitrypsin DeficiencyCharlie Strange, M.D. and Sabrina Janciauskiene, Ph.D. Chapter 10. The Marfan SyndromeAmaresh Nath, M.D and Enid Neptune, M.D.Chapter 11. Surfactant Deficiency Disorders SP-B and ABCA3Larry Nogee, M.D.Chapter 12. Pulmonary Capillary Hemangiomatosis Edward D. Chan, M.D., Kathryn Chmura, B.A, and Andrew Sullivan, M.D.Chapter 13. Goodpasture's SyndromeGangadar Taduri, M.D., D.M., Raghu Kalluri, Ph.D., and Ralph P. Panos, M.D. Chapter 14. Primary Ciliary Diskinesia Michael R. Knowles, M.D., Hilda Morillas, M.D., Margaret W. Leigh, M.D., Maimoona Zariwala, Ph.D.Chapter 15. Pulmonary Alveolar MicrolithiasisKoichi Hagiwara, MD, Takeshi Jokoh, M.D., Teruo Tachibana, MD Chapter 16. Cystic Fibrosis Andre Cantin, M.D.Chapter 17. Pulmonary Langerhan´s CellHistiocytosis Robert Vassallo, M.D.Chapter 18. SarcoidosisRalph Panos, M.D. and Andrew Fontenot, M.D.Chapter 19. Scleroderma Lung DiseaseBrent Kinder, M.D.

The study of rare lung disorders enhances our understanding of common pulmonary diseases such as fibrosis and emphysema. Molecular Basis of Pulmonary Disease: Insights from Rare Lung Disorders brings together a panel of distinguished clinicians and molecular scientists who are experts in a range of rare lung diseases and their underlying molecular defects. Each chapter focuses on the pathogenic mechanisms and therapeutic targets suggested by basic research and follows an easy-to-read format: brief introduction followed by discussion of epidemiology, genetic basis and molecular pathogenesis, animal models, clinical presentation, diagnostic approaches, conventional management and treatment strategies, as well as future therapeutic targets and directions. Disorders ranging from the Marfan and Goodpasture´s syndromes to Sarcoidosis and alpha one antitrypsin deficiency are treated in detail. Written for pulmonary clinicians and scientists alike, Molecular Basis of Pulmonary Disease: Insights from Rare Lung Disorders is a comprehensive and invaluable nesource that sheds new light on the molecular mechanisms influencing the clinical presentation and treatment strategies for these debilitating disorders.


From the reviews:

"This unique book attempts to briefly review the clinical manifestations and evolution of a few uncommon, mostly very rare pulmonary disorders, some of which even subspecialist pulmonologists rarely or never encounter during their careers. ... The editors derive insight and input from contributors of eclectic knowledge and experience. ... Certainly, the audience would be limited to basic scientists and a modicum of clinicians with unique interests. ... The book achieves its likely intended goals well. ... a potentially useful addition to my medical library.” (Joel C. Seidman, Doody´s Review Service, July, 2010)

The study of rare lung disorders enhances our understanding of common pulmonary diseases such as fibrosis and emphysema. Molecular Basis of Pulmonary Disease: Insights from Rare Lung Disorders brings together a panel of distinguished clinicians and molecular scientists who are experts in a range of rare lung diseases and their underlying molecular defects. Each chapter focuses on the pathogenic mechanisms and therapeutic targets suggested by basic research and follows an easy-to-read format: brief introduction followed by discussion of epidemiology, genetic basis and molecular pathogenesis, animal models, clinical presentation, diagnostic approaches, conventional management and treatment strategies, as well as future therapeutic targets and directions. Disorders ranging from the Marfan and Goodpasture's syndromes to Sarcoidosis and alpha one antitrypsin deficiency are treated in detail. Written for pulmonary clinicians and scientists alike, Molecular Basis of Pulmonary Disease: Insights from Rare Lung Disorders is a comprehensive and invaluable nesource that sheds new light on the molecular mechanisms influencing the clinical presentation and treatment strategies for these debilitating disorders.


Chapter 1. A Clinical Approach to Rare Lung DiseasesRalph Panos, M.D.Chapter 2. Clinical Trials for Rare Lung DiseasesJeffrey Krischer, Ph.D.Chapter 3. Idiopathic and Familial Pulmonary Arterial HypertensionJean M. Elwing, M.D., Gail Deutsch, M.D., William C. Nichols, Ph.D., and Timothy LeCras, Ph.D.,Chapter 4. LymphangioleiomyomatosisFrancis X. McCormack, M.D, and Elizabeth P. Henske, M.D., Ph.D.Chapter 5. Autoimmune Pulmonary Alveolar ProteinosisBruce Trapnell, M.D., Koh Nakata, M.D., Ph.D., and Yoshikazu Inoue, M.D., Ph.D.Chapter 6. Mutations in Surfactant Protein C and Interstitial Lung DiseaseJames P. Bridges, Ph. D. and Ralph Panos, M.D.Chapter 7. Hereditary Hemorrhagic TelangiectasiaClaire Shovlin, M.D and S. Paul Oh, Ph.D.Chapter 8. Hermansky Pudlak SyndromeLisa Young, M.D. and Bill Gahl, M.D., Ph.D.Chapter 9. Alpha One Antitrypsin DeficiencyCharlie Strange, M.D. and Sabrina Janciauskiene, Ph.D.Chapter 10. The Marfan SyndromeAmaresh Nath, M.D and Enid Neptune, M.D.Chapter 11. Surfactant Deficiency Disorders SP-B and ABCA3Larry Nogee, M.D.Chapter 12. Pulmonary Capillary HemangiomatosisEdward D. Chan, M.D., Kathryn Chmura, B.A, and Andrew Sullivan, M.D.Chapter 13. Goodpasture's SyndromeGangadar Taduri, M.D., D.M., Raghu Kalluri, Ph.D., and Ralph P. Panos, M.D.Chapter 14. Primary Ciliary DiskinesiaMichael R. Knowles, M.D., Hilda Morillas, M.D., Margaret W. Leigh, M.D., Maimoona Zariwala, Ph.D.Chapter 15. Pulmonary Alveolar MicrolithiasisKoichi Hagiwara, MD, Takeshi Jokoh, M.D., Teruo Tachibana, MDChapter 16. Cystic FibrosisAndre Cantin, M.D.Chapter 17. Pulmonary Langerhan's CellHistiocytosisRobert Vassallo, M.D.Chapter 18. SarcoidosisRalph Panos, M.D. and Andrew Fontenot, M.D.Chapter 19. Scleroderma Lung DiseaseBrent Kinder, M.D.

From the reviews:

"This unique book attempts to briefly review the clinical manifestations and evolution of a few uncommon, mostly very rare pulmonary disorders, some of which even subspecialist pulmonologists rarely or never encounter during their careers. ... The editors derive insight and input from contributors of eclectic knowledge and experience. ... Certainly, the audience would be limited to basic scientists and a modicum of clinicians with unique interests. ... The book achieves its likely intended goals well. ... a potentially useful addition to my medical library." (Joel C. Seidman, Doody's Review Service, July, 2010)

Inhaltsverzeichnis



Chapter 1. A Clinical Approach to Rare Lung Diseases Ralph Panos, M.D. Chapter 2. Clinical Trials for Rare Lung Diseases Jeffrey Krischer, Ph.D. Chapter 3. Idiopathic and Familial Pulmonary Arterial Hypertension Jean M. Elwing, M.D., Gail Deutsch, M.D., William C. Nichols, Ph.D., and Timothy LeCras, Ph.D., Chapter 4. Lymphangioleiomyomatosis Francis X. McCormack, M.D, and Elizabeth P. Henske, M.D., Ph.D. Chapter 5. Autoimmune Pulmonary Alveolar Proteinosis Bruce Trapnell, M.D., Koh Nakata, M.D., Ph.D., and Yoshikazu Inoue, M.D., Ph.D. Chapter 6. Mutations in Surfactant Protein C and Interstitial Lung Disease James P. Bridges, Ph. D. and Ralph Panos, M.D. Chapter 7. Hereditary Hemorrhagic Telangiectasia Claire Shovlin, M.D and S. Paul Oh, Ph.D. Chapter 8. Hermansky Pudlak Syndrome Lisa Young, M.D. and Bill Gahl, M.D., Ph.D. Chapter 9. Alpha One Antitrypsin Deficiency Charlie Strange, M.D. and Sabrina Janciauskiene, Ph.D. Chapter 10. The Marfan Syndrome Amaresh Nath, M.D and Enid Neptune, M.D. Chapter 11. Surfactant Deficiency Disorders SP-B and ABCA3 Larry Nogee, M.D. Chapter 12. Pulmonary Capillary Hemangiomatosis Edward D. Chan, M.D., Kathryn Chmura, B.A, and Andrew Sullivan, M.D. Chapter 13. Goodpasture's Syndrome Gangadar Taduri, M.D., D.M., Raghu Kalluri, Ph.D., and Ralph P. Panos, M.D. Chapter 14. Primary Ciliary Diskinesia Michael R. Knowles, M.D., Hilda Morillas, M.D., Margaret W. Leigh, M.D., Maimoona Zariwala, Ph.D. Chapter 15. Pulmonary Alveolar Microlithiasis Koichi Hagiwara, MD, Takeshi Jokoh, M.D., Teruo Tachibana, MD Chapter 16. Cystic Fibrosis Andre Cantin, M.D. Chapter 17. Pulmonary Langerhan's CellHistiocytosis Robert Vassallo, M.D. Chapter 18. Sarcoidosis Ralph Panos, M.D. and Andrew Fontenot, M.D. Chapter 19. Scleroderma Lung Disease Brent Kinder, M.D.


Klappentext

theRareLungDiseaseConsortium,anetworkof13USandinter- tionalsitesthatiscurrentlyconductingclinicaltrialsandstudiesinLAM,alphaone antitrypsin de ciency, pediatric interstitial lung disease, and PAP. It has been a rare privilegetoworkonsuchfascinatingdiseaseswithsuchcapableinvestigatorsfromall overtheworldoverthepast6years. v vi Preface Theformatforthisvolumeisunique. Mostchaptershavebeenauthoredbyacli- cianandabasicscientistwhoareexpertinthediseasetopicandunderlyingmolecular defect,respectively. Theirchargewastofocusonthegeneticbasisandmolecularpat- genesisofdisease,animalmodels,clinicalfeatures,diagnosticapproach,conventional managementandtreatment,andfuturetherapeutictargetsanddirections. Theintentwas nottoprovideabroadoverview,butrathertoshedlightonthemolecularmechanisms thatevoketheclinicalpresentationandengendertreatmentstrategiesforeachdisease. Wehopethatthisapproachwillproveusefulforpulmonarycliniciansandscientists alike. Wethankourwives,Holly,Jean,andVicky,fortheirsupportandindulgencewith latenightemailsandwork- lledweekends,Dr. Roundsfortheinvitationtowritethe book,andalloftheauthorswhocontributed. FrancisMcCormack,MD RalphPanos,MD BruceTrapnell,MD Contents Preface. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . v Contributors. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ix 1 AClinicalApproachtoRareLungDiseases. . . . . . . . . . . . . . . . 1 RalphJ. Panos 2 ClinicalTrialsforRareLungDiseases. . . . . . . . . . . . . . . . . . . 31 JeffreyKrischer 3 IdiopathicandFamilialPulmonaryArterialHypertension . . . . . . . . 39 JeanM. Elwing,GailH. Deutsch,WilliamC. Nichols, andTimothyD. LeCras 4 Lymphangioleiomyomatosis. . . . . . . . . . . . . . . . . . . . . . . . 85 ElizabethP. HenskeandFrancisX. McCormack 5 AutoimmunePulmonaryAlveolarProteinosis. . . . . . . . . . . . . . . 111 BruceC. Trapnell,KohNakata,andYoshikazuInoue 6 MutationsinSurfactantProteinCandInterstitialLungDisease . . . . . 133 RalphJ. Panosan




Comprehensive, state-of-the-art review of rare lung diseases

Thoroughly sheds light on the molecular mechanisms that evoke the clinical presentation and engender treatment strategies for each rare lung disease

Covers all aspects of such disorders as pulmonary alveolar proteinosis (PAP), pulmonary alveolar microlithiasis (PAM), inherited disorders of surfactant metabolism, and pulmonary arterial hypertension, to name just several

Includes supplementary material: sn.pub/extras

leseprobe



Datenschutz-Einstellungen